Antibody Drug Conjugates Reimagined

Firefly specializes in Degrader Antibody Conjugates (DACs) which combine the unique strengths of ADCs with selective protein degraders. Our state-of-the-art platform results in highly specific delivery of degraders to target tissue.

Firefly lights the way

Accessing new classes of ADC payloads requires new technology. At Firefly, we have developed a proprietary platform to capture this opportunity at scale.

Firefly lights the way
diverse minds, bright sparks

Diverse minds, bright sparks

Firefly is a team of innovators from diverse backgrounds. We are dedicated to exploring complex and exciting challenges.

We're looking for
Impactful Dependable Collaborative Positive
individuals to join our quest!

Firefly News

Keep up to date with what’s happening at Firefly!